Brief: DiaMedica Initiates Pivotal Trial Of DM199 For Treatment Of Acute Ischemic Stroke
13/09/2021 13:51
Sept 13 (Reuters) - DiaMedica Therapeutics Inc DMAC.O :
* DIAMEDICA THERAPEUTICS INITIATES PIVOTAL TRIAL OF DM199
FOR THE
TREATMENT OF ACUTE ISCHEMIC STROKE
Source text for Eikon: ID:nBw3BqjNQa
Further company coverage: DMAC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on DiaMedica Therapeutics
See all newsBrief: Diamedica Therapeutics Announces Enrollment Of 200Th Patient In Remedy2 Phase 2/3 Acute Ischemic Stroke Trial
DiaMedica Q2 net loss widen less than expected
DiaMedica Therapeutics Inc expected to post a loss of 20 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Qualcomm, Robinhood
Brief: Diamedica Receives FDA Feedback On Dm199 Preeclampsia Nonclinical Program